# MGAT2

## Overview
MGAT2 is a gene that encodes the enzyme alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, a crucial component in the N-glycosylation pathway. This enzyme, categorized as a glycosyltransferase, is integral to the synthesis of complex N-glycans within the Golgi apparatus, which are essential for various cellular functions, including protein stability, maturation, and immune system development (Wang2001Modeling; Poskanzer2020Immune). The MGAT2 protein is an integral membrane protein with two transmembrane domains, facilitating its localization to the endoplasmic reticulum (McFie2016Membrane). It plays a significant role in the diversification of protein-bound N-glycan structures, impacting cell signaling and immune responses (Ryan2013Mgat2). Mutations in the MGAT2 gene can lead to Congenital Disorder of Glycosylation type IIa, highlighting its importance in maintaining normal physiological functions (CORMIERDAIRE2000Congenital).

## Structure
The human MGAT2 protein is an integral membrane protein involved in lipid metabolism, specifically in the synthesis of diacylglycerol. It is characterized by two transmembrane domains, with the first domain located between amino acids 20-42 and the second between amino acids 50-75. These domains are crucial for its localization to the endoplasmic reticulum (ER) (McFie2016Membrane). The C-terminal region, spanning amino acids 134-334, is exposed to the cytosol, while the N-terminus is partially embedded in the ER membrane (McFie2016Membrane).

MGAT2 forms oligomeric structures, existing as dimers and tetramers, which are stable even under denaturing conditions (Zhang2014Monoacylglycerol). It can heterodimerize with diacylglycerol acyltransferase-1 (DGAT1), enhancing triglyceride synthesis, but does not form heterodimers with DGAT2 despite sequence homology (Zhang2014Monoacylglycerol).

The protein contains a histidine-proline-histidine-glycine sequence, which is thought to be part of its active site, and has five cysteine residues important for its catalytic function. Mutations in these cysteines can significantly alter MGAT2 activity (McFie2016Membrane). MGAT2 does not translocate to lipid droplets but can interact with them when co-expressed with DGAT2 (McFie2016Membrane).

## Function
The MGAT2 gene encodes the enzyme UDP-GlcNAc:α-6-D-mannoside β-1,2-N-acetylglucosaminyltransferase II (GlcNAcT-II), which is crucial for the synthesis of complex N-glycans in the Golgi apparatus. These N-glycans are essential for various physiological functions, including protein stability and maturation in the endoplasmic reticulum (Wang2001Modeling). In healthy human cells, MGAT2 is involved in the proper glycosylation of proteins, a critical post-translational modification necessary for immune system development and function (Poskanzer2020Immune). The enzyme plays a significant role in the N-linked glycan synthetic pathway, which is vital for T-cell function and the activity of serum proteins (Poskanzer2020Immune).

MGAT2 is also involved in the processing and diversification of protein-bound N-glycan structures, impacting processes like cell signaling and immune response (Ryan2013Mgat2). The enzyme's activity is crucial for the presentation of glycoantigens by antigen-presenting cells to T cells, highlighting its importance in the immune response (Ryan2013Mgat2). Deficiencies in MGAT2 can lead to significant physiological disruptions, underscoring its role in maintaining normal physiological functions (Wang2001Modeling).

## Clinical Significance
Mutations in the MGAT2 gene lead to Congenital Disorder of Glycosylation type IIa (CDG-IIa), an autosomal recessive disorder characterized by a deficiency in complex N-glycans. This deficiency results in a range of symptoms, including severe neurological issues such as psychomotor retardation, cortical atrophy, and delayed myelination, as well as systemic manifestations like growth retardation, dysmorphic facial features, and chronic feeding difficulties (Wang2001Modeling; CORMIERDAIRE2000Congenital; Thiel2011Mouse). Patients may also experience immune dysfunction, with variations in severity, and are prone to infections due to defects in B and T cell development (Wang2001Modeling; Poskanzer2020Immune).

MGAT2 mutations affect the enzyme UDP-N-acetylglucosamine:α6-D-mannoside-ß1,2-N-acetylglucosaminyltransferase II, leading to impaired glycan processing and altered glycoprotein patterns (CORMIERDAIRE2000Congenital; Thiel2011Mouse). In mouse models, MGAT2 deficiency results in physiological abnormalities such as osteopenia, scoliosis, and gastrointestinal dysfunction, which provide insights into the human condition (Wang2001Modeling). These findings underscore the critical role of MGAT2 in maintaining normal physiological processes and highlight the severe consequences of its dysfunction.

## Interactions
MGAT2, an enzyme involved in the N-glycosylation pathway, participates in various protein interactions within the Golgi apparatus. It forms specific sub-complexes with other N-acetylglucosaminyltransferases (MGATs) and Golgi alpha-mannosidase IIX (MAN2A2), which acts as a central hub for these interactions. MGAT2 interacts with MGAT1, MGAT3, and MAN2A2, but not with MGAT4B or MGAT5, indicating selective binding dynamics (KhoderAgha2019Nacetylglucosaminyltransferases). These interactions are characterized by competitive binding, where MGAT1 and MGAT3 can inhibit MGAT2's interaction with each other, suggesting they compete for the same binding interface (KhoderAgha2019Nacetylglucosaminyltransferases).

MGAT2 also forms ternary complexes with MGAT1 and various nucleotide sugar transporters (NSTs) such as A3 and A4, facilitating efficient synthesis of complex N-glycans (KhoderAgha2019Nacetylglucosaminyltransferases). These multi-enzyme-transporter assemblies are crucial for N-glycan processing, although the exact functional implications remain to be fully elucidated (KhoderAgha2019Nacetylglucosaminyltransferases). The interactions of MGAT2 with other proteins highlight its role in the glycosylation process, ensuring proper glycoprotein folding and processing within the Golgi membranes.


## References


[1. (Ryan2013Mgat2) S. O. Ryan, S. M. Leal, D. W. Abbott, E. Pearlman, and B. A. Cobb. Mgat2 ablation in the myeloid lineage leads to defective glycoantigen t cell responses. Glycobiology, 24(3):262–271, December 2013. URL: http://dx.doi.org/10.1093/glycob/cwt107, doi:10.1093/glycob/cwt107. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwt107)

[2. (KhoderAgha2019Nacetylglucosaminyltransferases) Fawzi Khoder-Agha, Paulina Sosicka, Maria Escriva Conde, Antti Hassinen, Tuomo Glumoff, Mariusz Olczak, and Sakari Kellokumpu. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme–multi-transporter assemblies in golgi membranes in vivo. Cellular and Molecular Life Sciences, 76(9):1821–1832, February 2019. URL: http://dx.doi.org/10.1007/s00018-019-03032-5, doi:10.1007/s00018-019-03032-5. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03032-5)

[3. (Thiel2011Mouse) Christian Thiel and Christian Körner. Mouse models for congenital disorders of glycosylation. Journal of Inherited Metabolic Disease, 34(4):879–889, February 2011. URL: http://dx.doi.org/10.1007/s10545-011-9295-7, doi:10.1007/s10545-011-9295-7. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10545-011-9295-7)

[4. (Wang2001Modeling) Y. Wang, J. Tan, M. Sutton-Smith, D. Ditto, M. Panico, R. M. Campbell, N. M. Varki, J. M. Long, J. Jaeken, S. R. Levinson, A. Wynshaw-Boris, H. R. Morris, D. Le, A. Dell, H. Schachter, and J. D. Marth. Modeling human congenital disorder of glycosylation type iia in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology, 11(12):1051–1070, December 2001. URL: http://dx.doi.org/10.1093/glycob/11.12.1051, doi:10.1093/glycob/11.12.1051. This article has 120 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/11.12.1051)

[5. (Zhang2014Monoacylglycerol) Jun Zhang, Dan Xu, Jia Nie, Jingsong Cao, Yonggong Zhai, Dewen Tong, and Yuguang Shi. Monoacylglycerol acyltransferase-2 is a tetrameric enzyme that selectively heterodimerizes with diacylglycerol acyltransferase-1. Journal of Biological Chemistry, 289(15):10909–10918, April 2014. URL: http://dx.doi.org/10.1074/jbc.M113.530022, doi:10.1074/jbc.m113.530022. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M113.530022)

[6. (McFie2016Membrane) Pamela J. McFie, Sabrina Izzard, Huyen Vu, Youzhi Jin, Erwan Beauchamp, Luc G. Berthiaume, and Scot J. Stone. Membrane topology of human monoacylglycerol acyltransferase-2 and identification of regions important for its localization to the endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1861(9):1192–1204, September 2016. URL: http://dx.doi.org/10.1016/j.bbalip.2016.06.021, doi:10.1016/j.bbalip.2016.06.021. This article has 3 citations.](https://doi.org/10.1016/j.bbalip.2016.06.021)

[7. (CORMIERDAIRE2000Congenital) V CORMIER-DAIRE. Congenital disorders of glycosylation iia cause growth retardation, mental retardation, and facial dysmorphism. Journal of Medical Genetics, 37(11):875–877, November 2000. URL: http://dx.doi.org/10.1136/jmg.37.11.875, doi:10.1136/jmg.37.11.875. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.37.11.875)

[8. (Poskanzer2020Immune) Sheri A. Poskanzer, Matthew J. Schultz, Coleman T. Turgeon, Noemi Vidal‐Folch, Kris Liedtke, Devin Oglesbee, Dimitar K. Gavrilov, Silvia Tortorelli, Dietrich Matern, Piero Rinaldo, James T. Bennett, Jenny M. Thies, Irene J. Chang, Anita E. Beck, Kimiyo Raymond, Eric J. Allenspach, and Christina Lam. Immune dysfunction in <scp>mgat2‐cdg</scp>: a clinical report and review of the literature. American Journal of Medical Genetics Part A, 185(1):213–218, October 2020. URL: http://dx.doi.org/10.1002/ajmg.a.61914, doi:10.1002/ajmg.a.61914. This article has 7 citations.](https://doi.org/10.1002/ajmg.a.61914)